Amylyx Pharmaceuticals Looking for Head, Commercial Strategy and Forecasting at Cambridge, MA Full Time

Amylyx was started in 2013 by two Brown University students who had an ambitious goal: to improve the lives of people with neurodegenerative diseases by addressing the root cause. Their research and close collaboration with the ALS community ultimately resulted in our first commercial product, which is now approved in the U.S. and conditionally approved in Canada.
At Amylyx, we’re bringing together talented people like you who are guided by our values to be Audacious, Curious, Authentic, Engaging and Accountable in the fight against neurodegenerative diseases like, ALS, Alzheimer’s disease, Wolfram Syndrome and others.
Rediscover your purpose and reimagine your career at a company whose founders, mission, and culture are unlike any other in life sciences—in all the best ways.
Recent milestones include:

• The U.S. Food and Drug Administration (FDA) approved RELYVRIO™ in September of 2022
• Health Canada approved ALBRIOZA™ with conditions in Canada in June of 2022
• AMX0035 is currently under review with the European Medicines Agency
• 350 employees globally, with headquarters in Cambridge, MA, US and Amsterdam, the Netherlands — and growing strong!

Position Summary
The Head of Commercial Strategies & Analytics is responsible for leveraging market knowledge and modeling expertise to generate in-depth, customer-focused analytical insights, articulate actionable recommendations, and to drive critical business decisions. Working closely with the Global Commercial Organization, Operations, Marketing, and Finance, the role is responsible for leading the development, analysis, and effective communication of the commercial 5-year roadmap. This position will coordinate launch sequencing and forecasting for current and future products at Amylyx. This role will be responsible for working directly with regional Commercial Leaders to align on a long-term vision, commercial assessment, and investment case development for the Amylyx portfolio of in-line and late stage assets. In addition, the role will also be responsible for leading / supporting portfolio wide and key strategic initiatives.
Responsibilities

• Develop, analyze, and effectively communicate all forecasts (including innovative forecast models) and assumptions for all global in-line market products and pre-launch assets
• Partner with the Chief Commercial Officer and regional Commercial Leaders to lead the development of the Global Commercial forecast and roadmap.
• Partner with stakeholders to align on assumptions and impact of current and future market events
• Partner with Global Marketing and Commercial Operations in utilizing output from primary and secondary market research to identify and assess high business impact events (e.g., current and future market events, Promotional Response, Sales Force Effectiveness, etc.)
• Lead engagement with Finance for the financial planning process and Supply Chain for the S&OP process.
• Work with the CCO to shape the overarching Commercial narrative for the Executive Leadership Team, Board of Directors, and investors, working in coordination with other functions to create the necessary supporting materials.
• Coordinate necessary analyses to evaluate strategic options to include launched countries as well as Base Plan / Strategic Roadmap considerations
• Lead the evaluation and integration of available data sources such as patient and market audit data, competitive intelligence, sales analytics, and managed care data
• Provide leadership, coaching and direction to the Commercial Strategies & Analytics team.
• Lead forecast modeling, including defining key assumptions (market share, price, competitors, etc.) for assets under consideration and a part of the portfolio.
• Maintain an understanding of external assets in development in core focus areas.
• Conduct commercial assessments during the due-diligence process by building a commercial perspective on target assets (e.g., market potential, possible peak sales and ramp up in various scenarios).
• Identify value drivers and relevant target populations for late-stage assets based on an understanding of the epidemiology / burden of disease, health economics, patient flows, current standards of care, etc.
• Support program teams to develop early forecast scenarios and provide initial asset value for the internal portfolio prioritization process. As asset progresses to mid/late stage, refine initial understanding of value drivers as identified during early development.
• Drive commercial business case for prioritization either through the traditional drug development process and develop/refine asset stewardship for core early portfolio assets.
• Support global team by driving pre-launch preparation for assets to ensure launch excellence.
• Support the annual strategic and operating plan process

Requirements

• A bachelor’s degree is required; MBA, or other advanced degree is preferred
• Minimum 10+ years of Pharma experience in industry, or a professional services environment, ideally in management consulting, serving the Life Science/Biotechnology industry.
• Proven business consulting expertise in disciplines such as growth strategies, go-to-market strategy, segmentation (advanced analytical), product and portfolio design, pricing, marketing, value proposition development, distribution strategy (omni-channel management, digitization, and channel orchestration), sales strategies (sales efficiency, processes, incentives, and motivations), and monetization strategies.
• Strong analytical skills with ability to distill insights/takeaways from large sets of data.
• Knowledge of and comfort with science and technical content.
• Effective presentation and communication abilities to succinctly present findings, takeaways, and key recommendations to a senior leadership audience.
• Demonstrated record of solving complex problems, managing individuals, and completing challenging projects activities within tight project timelines.
• Comfort with ambiguity, and complex “white space” environments.
• Understands trends in healthcare and pharmaceuticals; customer and stakeholder landscape, competitive dynamics, regulatory and access environment, delivery systems, channels and sources of business in the US and/or developed markets.
• Deep understanding of analytic tools/methods, ability to generate strong customer insights and market intelligence.
• Effectively links insights to implications to inform strategy, planning and execution

To stay connected with us, follow Amylyx Pharmaceuticals on LinkedIn.
To return to our website please click here .
Amylyx is proud to be an Equal Employment Opportunity employer. We do not discriminate based upon race, religion, color, national origin, gender (including pregnancy, childbirth, or related medical matters), sexual orientation, gender identity, gender expression, age, status as a protected veteran, status as an individual with a disability, or other applicable legally protected characteristics. Accommodations are available for candidates who require them in our selection process. If you need an accommodation, please let your Amylyx Talent Acquisition contact know.